Deepak Nath - Abbott Laboratories Insider

Abbott Laboratories -- USA Stock  

USD 62.65  1.72  2.82%

Senior Vice President - Abbott Vascular

Mr. Deepak S. Nath is Senior Vice President Abbott Vascular of the Company. Currently he is Vice President, Vascular, Commercial. Between 2014 to 2015 he is Vice President, Molecular Diagnostics. Between 2012 to 2014 he is Divisional Vice President and General Manager, Ibis. Between 2011 to 2012 he is Divisional Vice President, CEEMEA, Vascular. Between 2009 to 2011 he is Divisional Vice President and General Manager, Nordics and Eastern European Operations, Vascular.
Age: 43  President Since 2015      

Deepak Nath Latest Insider Activity

Management Efficiency

The company has Return on Asset of 2.85 % which means that on every $100 spent on asset it made $2.85 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 1.36 % implying that it generated $1.36 on every 100 dollars invested.
The company has 27.92 B in debt with debt to equity (D/E) ratio of 89.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. Abbott Laboratories has Current Ratio of 2.21 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives


Blaise ColemanEndo International plc
John HertiaBio Rad Laboratories Inc
Ronald HuttonBio Rad Laboratories Inc
Shawn SoderbergBio Rad Laboratories Inc
Amit SachdevVertex Pharmaceuticals Incorpor
Michael PariniVertex Pharmaceuticals Incorpor
Paul NavarreAllergan plc
Antonio PeraEndo International plc
Philippe SchaisonAllergan plc
Michael CrowleyBio Rad Laboratories Inc
Thomas GraneyVertex Pharmaceuticals Incorpor
Matthew MalettaEndo International plc
Ian SmithVertex Pharmaceuticals Incorpor
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
William MeuryAllergan plc
Camille FarhatEndo International plc
Robert StewartAllergan plc
Daniel RudioEndo International plc
Wayne SwantonAllergan plc
Michael PartridgeVertex Pharmaceuticals Incorpor
Paul SilvaVertex Pharmaceuticals Incorpor

Entity Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is headquartered in Abbott Park, Illinois. Abbott Laboratories operates under Medical Appliances Equipment classification in USA and traded on New York Stock Exchange. It employs 99000 people.Abbott Laboratories (ABT) is traded on New York Stock Exchange in USA. It is located in ILLINOIS, U.S.A and employs 99,000 people. Abbott Laboratories is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Equity Search Now

Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
Hide  View All  NextLaunch Equity Search

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Abbott Laboratories to your portfolio

Top Management

Abbott Laboratories Leadership Team
Scott White, President
Samuel Scott, Director
Deepak Nath, President
Jaime Contreras, President
Roger Bird, President
Nancy McKinstry, Director
Heather Mason, President
James Farrell, Director
Phebe Novakovic, Director
JeanYves Pavee, President
Andrew Lane, President
Roxanne Austin, Director
Georges Vos, President
Stephen Fussell, President
Thomas Freyman, EVP
Sally Blount, Director
Daniel Starks, Director
Thomas Frinzi, President
Eric Fain, President
John Capek, EVP
Robert Alpern, Director, Ph.D
Murthy Simhambhatla, President
Miles White, Chairman
Robert Ford, President
Glenn Tilton, Director
Richard Ashley, EVP
Michael Rousseau, President
Edward Liddy, Director
Hubert Allen, EVP
Charles Foltz, President
Brian Yoor, CFO
John Stratton, Director
Joseph Manning, President
Jared Watkin, President
William Osborn, Director
Brian Blaser, EVP
Michael Warmuth, President
Robert Funck, President
Daniel Salvadori, President

Stock Performance

Abbott Laboratories Performance Indicators